Cited by 363Endometriosis Research and TreatmentMenstrual Health and DisordersEctopic Pregnancy Diagnosis and Management

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis

Petta, Carlos A., Ferriani, Rui A., Abrao, Mauricio S., Hassan, Daniela, Rosa e Silva, Julio C., Podgaec, Sergio, Bahamondes, Luis·2005·Human Reproduction

DOI 10.1093/humrep/deh869

Open this paper in CoChat — free account

Abstract

BACKGROUND: The objective of this multicentre randomized, controlled clinical trial was to compare the efficacy of a levonorgestrel-releasing intrauterine system (LNG-IUS) and a depot-GnRH-analogue in the control of endometriosis-related pain over a period of six months. METHODS: Eighty-two women, 18 to 40 years of age (mean 30 years), with endometriosis, dysmenorrhoea and/or CPP, were randomized using a computer-generated system of sealed envelopes into either LNG-IUS (n = 39) or GnRH analogue (n = 43) treatment groups at three university centres. Daily scores of endometriosis-associated CPP were evaluated using the Visual Analogue Scale (VAS), daily bleeding score was calculated from bleeding calendars, and improvement in quality of life was evaluated using the Psychological General Well-Being Index Questionnaire (PGWBI). The pain score diary was based on the VAS in which women recorded the occurrence and intensity of pain on a daily basis. A monthly score was calculated from the result of the sum of the daily scores divided by the number of days in each observation period. RESULTS: CPP decreased significantly from the first month throughout the six months of therapy with both forms of treatment and there was no difference between the groups (P > 0.999). In both treatment groups, women with stage III and IV endometriosis showed a more rapid improvement in the VAS pain score than women with stage I and II of the disease (P < 0.002). LNG-IUS users had a higher bleeding score than GnRH-analogue users at all time points of observation with 34% and 71% of patients in the LNG-IUS and GnRH-analogue groups, respectively, reporting no bleeding during the first treatment month, and 70% and 98% reporting no bleeding during the sixth month. No difference was observed between groups with reference to improvement in quality of life. CONCLUSIONS: Both, the LNG-IUS and the GnRH-analogue were effective in the treatment of CPP-associated endometriosis, although no differences were observed between the two treatments. Among the additional advantages of the LNG-IUS is the fact that it does not provoke hypoestrogenism and that it requires only one medical intervention for its introduction every 5 years. This device could therefore become the treatment of choice for CPP-associated endometriosis in women who do not wish to conceive.

Integrity signals

Registry

Crossref · 10.1093/humrep/deh869

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Prentice, A., Deary, A., Goldbeck-Wood, S., Farquhar, C., & Smith, S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000346 · Cited by 116
Retracted
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Applied Multivariate Statistical Analysis.
Johnson, A., & Wichern, D. W. (1988) · Biometrics · doi:10.2307/2531616 · Cited by 11,374
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,918
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain
Koninckx, P. R., Meuleman, C., Demeyere, S., Lesaffre, E., & Cornillie, F. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54244-7 · Cited by 849
Untitled work
(1984) · Medical Entomology and Zoology · Cited by 741
Chronic Pelvic Pain
Howard, F. M. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02723-0 · Cited by 487
Pharmacological profile of progestins
Sitruk-Ware, R. L. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.01.001 · Cited by 371

Flagged first, then by citations

Show all 34 references

Sorted by citations

Items 201–300 of 363

Endometriosis
Taylor, R. N., & Lebovic, D. I. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00024-3 · Cited by 8
Surgery Versus Pharmacological Treatment for Endometriosis
Avraham, S., & Seidman, D. S. (2014) · Women s Health · doi:10.2217/whe.13.77 · Cited by 7
“A multicenter RCT demonstrated that the levonorgestrel intrauterine system was as effective as the GnRH analog for the treatment of endometriosis-related pain, with avoidance of hormonal suppression [22].”
Background
Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins
da Costa Pinheiro, D. J. P., Pereira, A. M. G., Antonini, M., Maria Albuquerque Salgado, I., Dias, A. T., & Lopes, R. G. C. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02647-y · Cited by 8
“According to some authors, progestins have fewer side effects than combined contraceptives and can be prescribed in various routes of administration, oral, injectable, implants, and intrauterine devices [9, 20–25].”
Background
Hormonal Contraception
Allen, R. H., Kaunitz, A. M., & Hickey, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00018-6 · Cited by 7
Guidelines for management of endometriosis
Kim, M.-R., Kim, S. H., Shin, J., Lee, S. R., Lee, J. R., Cho, S., Choi, Y. S., & Lee, B. S. (2011) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2011.54.8.399 · Cited by 7
Induction of a local pseudo-pregnancy for the treatment of endometriosis
Yuan, P., Huang, Y., Cheng, B., Zhang, J., & Xin, X. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.08.001 · Cited by 8
Safety of current strategies to manage moderate to severe pain in patients with endometriosis
Ferrero, S., Barra, F., Vatteroni, G., Rosato, F. P., Evangelisti, G., Paudice, M., & Vellone, V. G. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2547017 · Cited by 7
“Two six-month studies comparing LNG-IUD to leuprolide found comparable efficacy in reducing pain [99,100], while a third RCT found goserelin and LNG-IUD similarly effective over 24 weeks [101].”
Mirena and NuvaRing in Management in Dysfunctional Uterine Bleeding
Vasudeva, S., Malhotra, G., Gulati, S., & Chandel, Y. (2018) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2018.5.4.18 · Cited by 6
The Effectiveness of Phalleria macrocarpa Bioactive Fraction in Alleviating Endometriosis and/or Adenomyosis Related Pain
Wiweko, B., Puspita, C. G., Tjandrawinata, R. R., Situmorang, H., Harzif, A. K., Pratama, G., Sumapraja, K., Natadisastra, M., & Hestiantoro, A. (2015) · eJournal Kedokteran Indonesia · doi:10.23886/ejki.3.4824 · Cited by 6
Hormonal treatment for endometriosis associated pelvic pain.
Wong, W. S. F., & Lim, C. E. D. (2011) · Europe PMC (PubMed Central) · Cited by 6
Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques
Geoffron, S., Legendre, G., Daraï, É., & Chabbert‐Buffet, N. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.005 · Cited by 6
Local drug release systems in endometriosis
Petraglia, F., & Luisi, S. V. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701582216 · Cited by 6
“Although a systemic absorption is always present, determining some side-effects, the local absorption seems to result in superior effectiveness with limited adverse effects and increased patient compliance, particularly during long-term treatment [5,6].”
Background
Chronic Abdominal Pain of Gynecologic Causes: Diagnosis and Treatment
Yamamoto, M. P., Carillo, J. F., & Howard, F. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1992-5_10 · Cited by 5
Endometriosis for the Colorectal Surgeon
Slaughter, K. N., & Gala, R. B. (2010) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0030-1254293 · Cited by 6
“Petta et al found the LNG-IUD to be equally as effective as GnRH agonist therapy without provoking hypoestrogenic side effects.(66) LNG-IUD requires only one medical intervention every 5 years, and accordingly may be an attractive management option for women with endometriosis.”
Background
AVALIAÇÃO QUANTITATIVA DA DISPENSAÇÃO DE CONTRACEPTIVOS DE EMERGÊNCIA NA REGIÃO DE CURITIBA, PR, BRASIL, ENTRE 2012 E 2014
Oliveira, M. I. C., & de Oliveira, V. B. (2016) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v27.e4.a2015.pp248-252 · Cited by 5
Endometriosis
Taylor, R. N., & Lebovic, D. I. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00026-3 · Cited by 6
Progestins for the Treatment of Endometriosis: An Update
Lazzeri, L., Luisi, S. V., & Petraglia, F. (2010) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/228402651000200401 · Cited by 5
[Progress on medical treatment in the management of adenomyosis].
Baboo, K. D., Chen, Z., & Zhang, X. (2019) · PubMed Central · doi:10.3785/j.issn.1008-9292.2019.04.04 · Cited by 5
Contraceptive Devices for Women: Implants, Intrauterine Devices and Other Products
Craik, J., & Rowlands, S. (2014) · Springer eBooks · doi:10.1007/978-3-319-12406-3_8 · Cited by 5
Lawsuits against Mirena®: Potential impact on public health
Danvers, A. A., Stuart, G. S., & Bryant, A. G. (2014) · Contraception · doi:10.1016/j.contraception.2014.03.013 · Cited by 5
Treatment of chronic pelvic pain in men and women
Moise, G., Capodice, J. L., & Winfree, C. J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.5.507 · Cited by 5
Randomized Clinical Trial of a Levonorgestrel-Releasing Intrauterine System and a Depot GnRH Analogue for the Treatment of Chronic Pelvic Pain in Women With Endometriosis
Barnes, R. B. (2006) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(08)70527-7 · Cited by 5
Endometriosis and adenomyosis
Vargas, M. V., & Huang, K. (2018) · Evidence-based Obstetrics Gynaecology · doi:10.1002/9781119072980.ch8 · Cited by 2
Approaching ovarian endometrioma with medical therapy
Vignali, M., SOLIMA, E., BARBERA, V., BECHERINI, C., & BELLONI, G. M. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.20.04751-6 · Cited by 4
Measures Used to Assess Chronic Pelvic Pain in Randomized Controlled Clinical Trials: A Systematic Review
Ferreira, M. B. C., Mitidieri, A. M. D. S., Silva, J. C. R. E., Poli‐Neto, O. B., Nogueira, A. A., & dos Reis, F. J. C. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12340 · Cited by 4
Success of uterus-preserving treatments for abnormal uterine bleeding, chronic pelvic pain, and symptomatic fibroids: age and bridges to menopause
Learman, L. A., Nakagawa, S., Gregorich, S. E., Jackson, R., Jacoby, A. F., & Kuppermann, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.12.052 · Cited by 4
Considering the risks and benefits of intrauterine devices: should clinician advice now be changed?
Bahamondes, L. G., & Bahamondes, M. V. (2012) · Clinical Practice · doi:10.2217/cpr.12.72 · Cited by 4
Self-citation
Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility
Bedaiwy, M. A. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.06.001 · Cited by 4
Radiotherapy for inoperable and refractory endometriosis presenting with massive hemorrhage: a case report
Nomiya, T., Harada, M., Sudo, H., Ota, I., Ichikawa, M., Suzuki, M., Murakami, M., & Nemoto, K. (2012) · Journal of Medical Case Reports · doi:10.1186/1752-1947-6-308 · Cited by 4
“In general, pain relievers and hormonal supplements are prescribed during menopause [1-6].”
Background
Stressors, psychological well-being, and overall health amongst students from public and private dental schools
Muniz, F. W. M. G., de Oliveira, M. B. L., Barros, I. D., de Oliveira, P. M. C., Rodrigues, L. K. A., & Carvalho, R. D. S. (2018) · Brazilian journal of oral sciences/Brazilian Journal of Oral Sciences · doi:10.20396/bjos.v17i0.8654216 · Cited by 4
Abnormal Uterine Bleeding
Asanka, G. (2017) · doi:10.33425/2639-9342.1026 · Cited by 4
Medical Therapies: Progestins
Horne, A. W., & Critchley, H. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch34 · Cited by 4
Aplicação de dispositivo intra-uterino liberador de levonorgestrel, previamente a ciclos de fertilização in vitro, nas portadoras de adenomiose
Donadio, N., Donadio, N. F., Dotore, A., Silva, F. F., Ribeiro, P. A., & Aoki, T. (2006) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032006000800006 · Cited by 3
Effectiveness and Safety of Postoperative Medical Treatments Following Fertility‐Preserving Surgery for Endometriosis: A Network Meta‐Analysis
Xiong, Y., Huang, W., Wang, C., Ma, W., Jin, S., Lin, J., Deng, X., Peng, Y., Huang, Y., Du, X., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.70016 · Cited by 3
“Furthermore, LNG-IUS decreases the production of thromboxane A2 and prostaglandin I 2 in the endometrium, reducing uterine muscle spasms and alleviating dysmenorrhea symptoms [41, 42].”
Conservative management in ureteric hydronephrosis due to deep endometriosis: Could the levonorgestrel-intrauterine device be an option?
Simon, E. D. S., Tejerizo-García, A., Muñoz, J. L. B., Alvarez-Domı́nguez, C., Marqueta, L., & López, J. S. J. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1286467 · Cited by 3
“Those Levonorgestrel-IUD characteristics may explain the observed effectiveness in the ureteric involvement of the reported cases (Fedele et al. 2001; Vercellini et al. 2003; Lockhat et al. 2004; Lockhat et al. 2005; Petta et al. 2005; Bayoglu Tekin et al. 2011): doublepigtail stent implantation solves the emergency h…”
Background
Long-acting Reversible Contraceptives - IUDS/IUS and Implants: A Review
Mohit, A., Hussain, M. S., Mohapatra, C., Sharma, S., & Sharma, R. K. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v68i01.023 · Cited by 3
Brief update on endometriosis treatment
Al‐Jefout, M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.01.002 · Cited by 3
Medicated intrauterine systems for treatment of endometriosis-associated pain
Muzii, L. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.06.010 · Cited by 3
Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
Miranda, L., de Sousa, M. H., Faúndes, A., & Juliato, C. R. T. (2021) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1726056 · Cited by 3
Chapter 3 Medical Treatment
(2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30736-2 · Cited by 3
Endometriosis.
Ferrero, S., Remorgida, V., & Venturini, P. L. (2010) · Europe PMC (PubMed Central) · Cited by 3
An Investigation into the Surgical Treatment of Endometriosis.
Barton‐Smith, P. (2010) · Surrey Research Insight Open Access (The University of Surrey) · Cited by 3
The role of immunology in the etiopathogenesis, diagnosis and treatment of endometriosis O papel da imunologia na etiopatogenia, diagnóstico e tratamento da endometriose
Podgaec, S., & Abrão, M. S. (2005) · Cited by 3
Self-citation
Safety and efficacy of hormonal therapies used to treat endometriosis in women suffering migraine
Perrone, U., Barra, F., Evangelisti, G., Izzotti, A., Gustavino, C., Antonelli, A., Maggiore, U. L. R., & Ferrero, S. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2627190 · Cited by 2
Management of endometriosis: a call to multidisciplinary approach
Duncan, J.-M., Delara, R., Ranieri, G., & Wasson, M. (2024) · Journal of Osteopathic Medicine · doi:10.1515/jom-2024-0105 · Cited by 4
Endometriosis: Current and Emerging Therapies
Hansen, K. A., & Eyster, K. M. (2011) · Clinical Medicine Reviews in Women s Health · doi:10.4137/cmrwh.s3269 · Cited by 2
Advances in endometriosis treatment
Sheaves, C. (2013) · The Nurse Practitioner · doi:10.1097/01.npr.0000425826.90435.a8 · Cited by 2
Faut-il réellement opérer les lésions infiltrantes d’endométriose ? – Non « Choisir le réalisme et non l’idéalisme »
Fernandez, H., Deffieux, X., Faivre, E., & Gervaise, A. (2008) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2007.12.007 · Cited by 2
Laparoscopic Excision of Endometrioma
Ebrahimi, N. A. A.-H. A. (2008) · World Journal of Laparoscopic Surgery with DVD · doi:10.5005/jp-journals-10007-1060 · Cited by 2
Management of Endometriosis
Gupta, S., Harlev, A., Agarwal, A. K., Rakhit, M., Ellis-Kahana, J., & Parikh, S. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_10 · Cited by 2
Chronic Pelvic Pain: An Overview
Goel, J. K., & Goel, S. (2013) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1249 · Cited by 2
Gynecologic Pain in Adolescents
McCracken, K. A. (2016) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-016-0060-x · Cited by 2
“Studies have randomized women with known endometriosis to LNG-IUD or gonadotropin-releasing hormone agonists, and both treatments were found to be effective for pain control [13, 14], while the LNG-IUD had higher continuation rates and lower pain scores at 3 years [15].”
Background
Medical Management of Pain Associated With Endometriosis
(2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34592-3 · Cited by 1
The issues of endometriosis hormonal treatment in reproductive age women
Ivanov, I. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2022-001 · Cited by 1
Die medikamentöse Therapie der Patientin mit Endometriose
Lermann, J. H., Hackl, J., Burghaus, S., Hildebrandt, T., Fahlbusch, C., Renner, S. P., & Beckmann, M. W. (2017) · Frauenheilkunde up2date · doi:10.1055/s-0042-122581 · Cited by 1
Intrauterine Contraception: Comparison of the Copper T Intrauterine Device with the Levonorgestrel Intrauterine Systems
Ohly, N. T., & Westhoff, C. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20185-6_10 · Cited by 1
Progestins in the Medical Management of Endometriosis
Singh, P., & Batra, S. (2017) · Journal of medical research/The journal of medical research · Cited by 1
Dienogest: Uma nova opção terapêutica em endometriose
Bahamondes, L. G., & Camargos, A. F. (2012) · Cited by 1
Self-citation
Endometriosis
Reza, M., Mazloomfard, M. M., & Ansari, A. (2012) · InTech eBooks · doi:10.5772/32760 · Cited by 1
Hormonal Therapy in Endometriosis and Adenomyosis: Progestins
Darıcı, E., & Oral, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-97236-3_41 · Cited by 1
Efficacy of non-pharmacological therapies in chronic pelvic pain of endometriosis: a systematic review and meta-analysis
Dantas, H. D. S., Oliveira, M., da Silva, T. C. D. L. A., de Oliveira, J. M. P., de Carvalho, M. L. A. S., & Micussi, M. T. A. B. C. (2025) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2025.103006 · Cited by 1
Tratamento terapêutico multi-profissional para endometriose com dor pélvica
Caldeira, R. P., Noronha, V. M. A., de Oliveira, B. E. C., & de Amorim, F. G. P. (2008) · Universitas Ciências da Saúde · doi:10.5102/ucs.v6i1.633 · Cited by 1
“…no volume mamário, ganho de peso, diminuição na libido, insônia, perda de massa óssea (NAVARRO et al., 2006; HOWARD, 2003; DULEBA et al., 1996) Petta et al. (2005) realizaram um estudo randomizado com um total de 82 mulheres com endometriose, dismenorréia ou dor pélvica crônica, dividas em 2…”
Background
Is Idiopathic Chronic Pelvic Pain a Treatable Entity: A Comment
Priya, K., & Rajaram, S. (2016) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000199 · Cited by 1
ENDOMETRİOZİSE BAĞLI AĞRI TEDAVİSİNDE LEVONORGESTREL SALGILAYAN RAHİM İÇİ ARAÇ SİSTEMİ (LNG-RİA) VE NAPROKSEN SODYUM ETKİNLİĞİ KARŞILAŞTIRILMASI
Arslan, Ş. T., Börekçi, B., & Yılmaz, E. P. T. (2016) · Mustafa Kemal Üniversitesi Tıp Dergisi · doi:10.17944/mkutfd.287836 · Cited by 1
Consensus canadien sur la contraception (partie 3 de 4): chapitre 7 - Contraception intra-utérine
Black, A., & Guilbert, É. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.02.124 · Cited by 1
Baseline endometriosis-associated pain burden: Data from 1600+ women enrolled in elagolix clinical trials
Leyland, N. A., Estes, S. J., Eichner, S. F., Soliman, A. M., Mai, Y., Snabes, M. C., Taylor, H. S., & Surrey, E. S. (2019) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/2284026519864232 · Cited by 1
Therapeutic efficacy of Mirena in gynecologic disease
Lee, J. Y. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.8.459 · Cited by 1
Hormonal Contraception
Hickey, M., & Kaunitz, A. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00018-3 · Cited by 1
Efficacy and safety of Elagolix in the treatment of endometriosis associated pain: a systematic review and network meta-analysis
Mattar, O. M., Namous, L. O., Ros, M. H., Fathi, M., Elgendy, F. A., M.elghazaly, S., Ibrahim, A. H., Gadallah, A., Faraag, E., Sayed, O., et al. (2021) · Proceedings in Obstetrics and Gynecology · doi:10.17077/2154-4751.1510 · Cited by 1
Intrauterine Contraception
Shimoni, N., Bishop, I. J., & Westhoff, C. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-46391-5_8 · Cited by 1
Perspective Chapter: Modern Birth Control Methods
Kindi, R. A., Salmani, A. A. A., Hadhrami, R. A., Sumri, S. A., & Sumri, H. H. A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103858 · Cited by 1
Medikamentöse Therapie der Endometriose
Schäfer, S. D. (2013) · Der Gynäkologe · doi:10.1007/s00129-013-3218-7 · Cited by 1
Medical Therapies: Randomized Controlled Trials/Traditional Medical Therapies
JOHNSON, N. P. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch33 · Cited by 1
Medicated intrauterine devices for contraception and their therapeutic effects
Luukkainen, T., & Pakarinen, P. I. (2006) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.1.2.195 · Cited by 1
Padrões de resposta imune em pacientes com endometriose
Podgaec, S. (2006) · doi:10.11606/t.5.2006.tde-31102006-105026 · Cited by 1
Self-citation
Levonorgestrel-releasing intrauterine device for symptomatic endometriosis following surgery
Houston, B. L., Al-Inany, H. G., Farquhar, C. M., & Abou-Setta, A. M. (2013) · Evidence Based Women s Health Journal · doi:10.1097/01.ebx.0000427509.23062.24 · Cited by 1
Adénomyose
Belaisch, J. (2006) · Imagerie de la Femme · doi:10.1016/s1776-9817(06)73037-1 · Cited by 1
Pain related genes in endometriosis: A meta-analysis
Saxena, M. (2015) · The Sydney eScholarship Repository (The University of Sydney)
Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH
Ferreira, R. A. (2009) · doi:10.11606/t.17.2009.tde-26092013-165121
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Buppasiri, P. (2007) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร
Contraception des cas particuliers
Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00013-9
Medikamentöse Therapie der chronischen Endometriose
Schäfer, S. D., & Kiesel, L. (2011) · Gynäkologische Endokrinologie · doi:10.1007/s10304-011-0441-y
Quimiocinas endometriais, celulas natural killer uterinas e mastocitos em usuarias do sistema intra-uterino liberador de levonorgestrel com e sem sangramento uterino no terceiro ano de uso
Pinto, A. C. P. (2006) · doi:10.47749/t/unicamp.2006.366636
Avaliação das dosagens das interleucinas 12 e 18 no sangue e no fluido peritoneal de pacientes com endometriose pélvica
Marino, F. F. L. D. O. (2007) · doi:10.11606/d.5.2007.tde-17042007-145858
Are gonadotropin-releasing hormone analogs and laparoscopic ablation equally effective treatments for endometriosis?
Baker, R. M., & Bunton, P. A. (2007) · Holmes Museum Of Anthropology (Wichita State University)
Cistos ovarianos funcionais em usuarias de implantes contraceptivos liberadores de etonogestrel ou levonorgestrel
Hidalgo, M. M. (2005) · doi:10.47749/t/unicamp.2005.359320
Hysterectomy and levonorgestrel-releasing intrauterine system in the treatment of menorrhagia : a 10-year randomized comparative trial
Heliövaara‐Peippo, S. (2012) · Työväentutkimus Vuosikirja
Surgical Therapies: Pouch of Douglas and Uterovaginal Pouch Resection for Endometriosis
Abrão, M. S., Podgaec, S., & Fernandes, L. F. C. (2011) · doi:10.1002/9781444398519.ch39
Self-citation
Histologia endometrial, densidade, calibre microvascular e matriz-metaloproteinase-3 em usuarias do sistema intra-uterino liberador de levonorgestrel ou do implante subdermico liberador de nestorone com e sem sangramento endometrial
Ribeiro, M. O. (2006) · doi:10.47749/t/unicamp.2006.370230
O efeito do sistema intra-uterino de levonorgestrel (SIU-LNG) no fluxo das artérias uterinas, volume uterino e espessura endometrial em pacientes com endometriose pélvica: estudo comparativo com o análogo de GNRH (GnRHa)
Manetta, L. A. (2007) · doi:10.11606/t.17.2007.tde-26092013-155810
Efeito do dispositivo intra-uterino com levonorgestrel e com cobre na vascularização sub-endometrial e no fluxo das artérias uterinas
Jiménez, M. F. (2007) · Americanae (AECID Library)
Manejo de los síntomas dolorosos de la endometriosis con dispositivo intrauterino de levonorgestrel en una paciente con pelvis congelada: reporte de caso
Ríos, J. F. D. L., & Molina, E. (2006) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.495
Actualización del uso de anticonceptivos en el tratamiento de la endometriosis
Triano-Sánchez, R., & de Prado-Prieto, L. (2011) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.09.004
Nondaily, nonoral and noncoital reversible contraception: increasing options for women
Culwell, K. R., & SHULMAN, L. P. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2.1.51
Chronische Endometriose: medikamentöse Therapie
Schäfer, S. D., & Kiesel, L. (2010) · Der Gynäkologe · doi:10.1007/s00129-010-2591-8
Chronic Pelvic Pain: Can You Guess the Cause?
Woodson, S. A. (2007) · Nursing for Women s Health · doi:10.1111/j.1751-486x.2007.00146.x
Pharmacological treatment of endometriosis: update from recent clinical trials
Ferrero, S., Remorgida, V., & Venturini, P. L. (2011) · Clinical Investigation · doi:10.4155/cli.10.4
Patient Acceptability, Safety and Efficacy of the Levonorgestrel-Releasing Intrauterine System (LNG-IUS)
Duffy, M. A. G. A. K. (2010) · Clinical Medicine Reviews in Women s Health · doi:10.4137/cmrwh.s5239
How much confidence to place in a negative result?
Roman, H., Hulsey, T., & Hulsey, T. C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.070
Hormonal strategy for the primary or secondary treatment of endometriosis
Lazzeri, L., Tosti, C., Pinzauti, S., Orlandini, C., Luisi, S. V., & Petraglia, F. (2012) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.12.46

Authors: Petta, C. A., Ferriani, R. A., Abrao, M. S., Hassan, D., Rosa e Silva, J. C., Podgaec, S., & Bahamondes, L.
Affiliations: Universidade Estadual de Campinas (UNICAMP) (BR)
Corresponding author: Petta, Carlos A.
ORCID: Petta, Carlos A.
Ferriani, Rui A.
Bahamondes, Luis
Venue: Human Reproduction
Publisher: Oxford University Press (OUP)
Published: 2005-03-24
Volume: 20
Issue: 7
Pages: 1993-1998
ISSN: 0268-1161 (ISSN-L)
1460-2350
DOI: 10.1093/humrep/deh869
OpenAlex: W2123134517
Cited by: 363
References: 34
Citations by year: 2026: 6 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 22 · 2021: 16 · 2020: 12 · 2019: 12 · 2018: 18 · 2017: 16 · 2016: 19 · 2015: 22 · 2014: 20 · 2013: 17 · 2012: 19
FWCI: 25.58
Type: journal article
Language: en
Open access: closed
Locations: Human Reproduction (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords: endometriosis, chronic pelvic pain, levonorgestrel-releasing intrauterine system, dysmenorrhea, endometriosis-associated pain, hemorrhage, quality of life, endometriosis stage, estrogen deficiency, treatment efficacy comparison, psychological well-being
MeSH terms: Adolescent, Adult, Delayed-Action Preparations, Endometriosis, Female, Humans, Intrauterine Devices, Medicated, Gonadotropin-Releasing Hormone, Leuprolide, Levonorgestrel, Pelvic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks